Pubbl/distr/stampa	Washington, D.C., : National Academies Press, 2009
Descrizione fisica	1 online resource (135 p.)
Disciplina	610.724
Altri autori (Persone)	PatlakMargie NassSharyl J MicheelChristine
Soggetto topico	Cancer - Treatment - United States Clinical trials
ISBN	0-309-17747-2 1-282-00804-8 9786612008047 0-309-12868-4
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	""Reviewers""; ""Contents""; ""Introduction""; ""Session 1A: Organization of the NCI Clinical Trials System""; ""Session 1B: Lessons from Non-Cooperative Group Multi-Center Clinical Trials""; ""Session 2: Barriers to Patient Recruitment and Physician Participation""; ""Session 3: Data Collection Standards and Monitoring""; ""Session 4: Costs of Cooperative Group Clinical Trials""; ""Summary and Wrap-Up""; ""References""; ""Abbreviations and Acronyms""; ""Glossary""; ""Appendix A: Workshop Agenda""; ""Appendix B: Workshop Speakers"" ""Appendix C: Letter from John Niederhuber, Director of the National Cancer Institute, to Members of the National Cancer Policy Forum""
Record Nr.	UNINA-9910777709403321

Edizione	[1st ed.]
Pubbl/distr/stampa	Washington, D.C., : National Academies Press, 2009
Descrizione fisica	1 online resource (135 p.)
Disciplina	610.724
Altri autori (Persone)	PatlakMargie NassSharyl J MicheelChristine
Soggetto topico	Cancer - Treatment - United States Clinical trials
ISBN	0-309-17747-2 1-282-00804-8 9786612008047 0-309-12868-4
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	""Reviewers""; ""Contents""; ""Introduction""; ""Session 1A: Organization of the NCI Clinical Trials System""; ""Session 1B: Lessons from Non-Cooperative Group Multi-Center Clinical Trials""; ""Session 2: Barriers to Patient Recruitment and Physician Participation""; ""Session 3: Data Collection Standards and Monitoring""; ""Session 4: Costs of Cooperative Group Clinical Trials""; ""Summary and Wrap-Up""; ""References""; ""Abbreviations and Acronyms""; ""Glossary""; ""Appendix A: Workshop Agenda""; ""Appendix B: Workshop Speakers"" ""Appendix C: Letter from John Niederhuber, Director of the National Cancer Institute, to Members of the National Cancer Policy Forum""
Record Nr.	UNINA-9910816136503321

Autore	Patlak Margie
Pubbl/distr/stampa	Washington, DC, : National Academies Press, 2011
Descrizione fisica	1 online resource (60 p.)
Disciplina	616.99405
Altri autori (Persone)	NassSharyl J BaloghErin
Soggetto topico	Cancer - Research Cancer - Treatment - United States
Soggetto genere / forma	Electronic books.
ISBN	1-283-13507-8 9786613135070 0-309-18740-0
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Contents""; ""The National Cancer Policy Summit: Opportunities and Challenges in Cancer Research and Care""; ""Appendix: Summit Agenda""
Record Nr.	UNINA-9910456521703321

Pubbl/distr/stampa	Washington, District of Columbia : , : The National Academies Press, , [2015]
Descrizione fisica	1 online resource (100 p.)
Disciplina	616.994075
Soggetto topico	Cancer - Treatment - United States Cancer - Genetic aspects Biochemical markers
Soggetto genere / forma	Electronic books.
ISBN	0-309-36858-8
Formato	Materiale a stampa
Livello bibliografico	Monografia
Lingua di pubblicazione	eng
Nota di contenuto	Front Matter; Reviewers; Acknowledgments; Contents; Boxes, Figures, and Tables; Acronyms; Workshop Summary; INTRODUCTION; MOLECULAR BIOLOGY REVOLUTION IN CANCER DIAGNOSIS AND TREATMENT; Lessons Learned from Single Analyte Tests; Next-Generation Sequencing; RNA Sequencing Tests; Tests for Circulating Tumor DNA; Business Climate for Developing Diagnostic Tests; CHALLENGES IN BIOMARKER TEST DEVELOPMENT; Setting Standards; Assessing Analytical Validity, Clinical Validity, and Clinical Utility; Sharing Data; REGULATORY OVERSIGHT CHALLENGES; Evolving Regulation of Laboratory-Developed Tests Companion DiagnosticsCLINICAL IMPLEMENTATION CHALLENGES; Insufficient or Inadequate Specimens; Tsunami of Information; Choosing the Best Test; Time Delays; Lack of Resources; Reporting Test Results; Incidental Findings; REIMBURSEMENT CHALLENGES; Lack of Evidence; Investigational and Off-Label Uses; Incidental Findings; Greater Expense, But Not Necessarily Greater Value; GATHERING THE EVIDENCE: INNOVATIVE CLINICAL TRIALS; Basket Trials; Lung-MAP Umbrella Trial; Challenges with Basket and Umbrella Trials; GATHERING THE EVIDENCE: COVERAGE DECISIONS; Coverage with Evidence Development The MolDx Approach to Test ReimbursementGreen Park Collaborative Recommendations; GATHERING THE EVIDENCE: DATABASES AND REGISTRIES; My Cancer Genome; ClinGen; Targeted Agent and Molecular Profiling Utilization Registry; Challenges in Using Databases; EDUCATION AND CLINICAL DECISION SUPPORT NEEDS; Guidelines; Treatment Pathways; RESEARCH NEEDS; CLOSING REMARKS; REFERENCES; Appendix: Workshop Statement of Task and Agenda; POLICY ISSUES IN THE DEVELOPMENT AND ADOPTION OF MOLECULARLY TARGETED THERAPIES FOR CANCER
Record Nr.	UNINA-9910460941803321